£1.6M
SERG Technologies secures £1.6m seed investment from Mercia and other backers to launch its NuRO platform.
The seed round will fund team expansion and technology development ahead of commercial launches in the UK and US.
"Our vision is to enable people with Parkinson’s and other neurodegenerative diseases and movement disorders to live healthier lives. NuRO could give patients and clinicians a much clearer picture of their condition, enabling treatment to be tuned accurately as needed. We’re excited to continue our work with leading hospitals and patient groups and to bring our technology to market."
